EUCTR2005-001218-42-IT进行中（未招募）不适用
Clinical role of PPAR gamma activator (pioglitazone) in reducing the gastric phlogosis in patiens with istological gastritis.
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2005年11月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Influence of the PPAR gamma -agonist Pioglitazone on endothelial function in the peripheral and myocardial vascular territories and on myocardial efficiency in obese subjects - PioglitazoneThere is an association between insulin resistance and endothelial dysfunction which is thought to be a critical factor in the development of vascular disease and thus an important factor in the development of atherosclerosis, hypertension and heart failure. Endothelial dysfunction can occur even in the vascular absence of angiographically defined disease and can be detected early in the spectrum of insulin resistance.EUCTR2004-003861-34-ATDepartment of Nuclear Medicine62
已完成
不适用
Can the use of the PPAR-gamma agonist rosiglitazon reverse the abnormal distribution of fat, as well as disturbances in glucose and lipid metabolism in HIV-associated lipodystrophy syndrome?HIV+ patients, with lipodystrophy (based on fat distribution disturbances), not using d4T nor a protease inhibitor.NL-OMON25981Academic medical centre, Dept of endocrinology and metabolism, F5-170, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands15
终止
1 期
Pioglitazone for Heroin and for Nicotine DependenceHeroin DependenceNicotine DependenceNCT01395797New York State Psychiatric Institute82
已完成
不适用
Peroxisome proliferator-activated receptor gamma (PPAR-gamma): a novel therapeutic target for asthma?RespiratoryAsthmaISRCTN80109258niversity of Nottingham (UK)100
已完成
不适用
Study of PPAR-gamma activating effect of angiotensin II receptor antagonist, telmisartaHypertensionJPRN-UMIN000014248Jichi Medical University43